Abstract
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the adequate immune response after vaccination as well as alongside with genetically engineered biologic drugs therapy. Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications.
Highlights
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review
Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications
Постепенное расширение охвата вакцинацией и даже неполный охват существенно снижают частоту инвазивных пневмококковых болезней во всех возрастных группах, а также способствуют формированию популяционного иммунитета, снижая уровень вирулентного бактерионосительства [5, 12, 17]
Summary
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. Что инфекции распространены у пациентов с ревматоидным артритом, и ревматологам необходимо вовремя выявлять факторы риска инфекционных осложнений [25]. В Российской Федерации до настоящего времени остро стоит проблема вакцинации хронически больных, а также детей, получающих иммуносупрессивную терапию или имеющих иммунодефицит, т.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
